Medical Weight Loss
Clinician guided weight loss that addresses the biology, psychology, and lifestyle factors behind weight — not just the number on a scale. Support with weight management and metabolic health from a nurse practitioner who knows your name and story.

Metabolic Assessment
Comprehensive labs & evaluation
GLP-1 Therapy
Semaglutide & tirzepatide options
Ongoing Monitoring
Labs, vitals & medication titration
Responsive Access
Direct provider check-ins
The Approach
Weight is not a character flaw. It is a complex biological, hormonal, and behavioral phenomenon — and it deserves a clinical response.
Obesity and metabolic dysfunction are chronic medical conditions influenced by neurohormonal signaling, insulin regulation, and genetic predisposition. Treatment requires medical strategy — not willpower. Weight is managed with the same clinical standards applied to other long-term conditions.
For many women, weight gain during perimenopause and menopause is directly tied to declining estrogen, progesterone, and testosterone levels. These hormonal shifts alter fat distribution, metabolic rate, insulin sensitivity, and appetite regulation. Evidence-based pharmacotherapy, including GLP-1–based therapies when clinically appropriate, can play a central role in restoring appetite regulation and supporting metabolic health during this transition.
Emotional eating, stress-driven food behaviors, and long-standing patterns around food are common and warrant thoughtful, non-judgmental evaluation.
The objective is clinically meaningful weight reduction and improved metabolic health. Treatment is structured to support steady progress under supervision, with adjustments made as needed based on response and tolerability.
The Options
Semaglutide (Ozempic®/Wegovy®) and tirzepatide (Mounjaro®/Zepbound®) represent a landmark advance in medical weight loss. These GLP-1 receptor agonists work by regulating appetite, slowing gastric emptying, improving insulin sensitivity, and — in the case of tirzepatide — also activating GIP receptors for enhanced metabolic effects. These peptides help reduce cravings and promote satiety — resulting in sustainable weight loss when paired with a reduced-calorie diet and increased physical activity.
Regular check-ins, lab reviews, and direct provider access throughout your treatment — so adjustments happen proactively, not reactively.
The Connection
Who Qualifies
Per FDA guidelines, this treatment is intended for:
BMI doesn't qualify?
You may opt for microdosing — very small, consistent doses to support your body, balance blood sugar, increase metabolic support, and reduce body-wide inflammation. There is no BMI requirement for microdosing.
Who Should Not Take GLP-1s
Pricing
Review medical history, discuss health goals, review baseline labs, and determine if Semaglutide or Tirzepatide is right for you.
Every 3 months via phone, telehealth, or in person to monitor results, progress, and review updated labs.
8 weeks of medication & supplies shipped to your door, billed every 2 months.
6 weeks of medication & supplies shipped to your door, billed every 6 weeks.
Prefer brand-name medication? Patients may obtain Ozempic®, Wegovy®, Mounjaro®, or Zepbound® directly through Eli Lilly Direct or Novo Nordisk. Monthly management fee is $75.
Compounding pharmacy (503A) operates fully within FDA compliance standards to ensure safety and efficacy.
Medical weight management services are provided on a private-pay basis and are not billed to insurance. GLP-1 medications prescribed through this practice are typically compounded formulations. Patients who prefer brand-name medications may obtain them directly through manufacturer programs such as Eli Lilly Direct or Novo Nordisk, while continuing clinical management through this practice for a monthly fee of $75. Lab costs are billed separately through your lab of choice.
The Benefits
GLP-1 therapy and integrative weight care can unlock benefits that go far beyond the number on the scale — touching your relationship with food, your mental clarity, and your metabolic health.
Address the behavioral and neurochemical patterns that drive eating beyond hunger — with compassionate, non-judgmental clinical support.
GLP-1 therapy has shown promising effects on reward-driven cravings — including alcohol — helping many patients experience a meaningful shift in compulsive urges.
Improved insulin sensitivity, reduced inflammation, and hormonal balance can have profound effects on mood, energy, and cognitive clarity.
Many patients describe a remarkable quieting of the constant mental chatter around food. Less obsession. More presence. More freedom.
Beyond weight loss, this is an opportunity to rebuild a healthier, more peaceful relationship with eating — one that supports your life rather than dominating it.
Book Online
Your initial medical weight loss evaluation is 45 minutes — a thorough review of your health history, metabolic profile, and goals. Choose the format that works best for you.
Both options include a full 45-minute medical evaluation. Telehealth available to patients in New York.
Begin Your Journey
If you're seeking greater clarity and balance in your health and well-being, please complete the short form to get started.
If You Are in Crisis
If you are in crisis, feeling suicidal, or experiencing a psychiatric emergency, please immediately call 911 or go to your closest emergency room. This form is not monitored in real time and is not appropriate for urgent or emergency situations.
In-person care available in Buffalo, NY. Secure telehealth services available to patients located in New York.
Time and attention are built into every visit — no rushed encounters.
Your privacy is paramount. All consultations are strictly confidential.
Ready to Get Started?
Schedule a complimentary 15-minute discovery call. Discovery calls are intended to help prospective patients understand the practice and determine whether the approach aligns with their needs.
Book a Discovery CallAll fields are confidential and HIPAA-compliant.